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ABSTRACT 
 
Aim: To evaluate the cardioprotective effects of resveratrol during hyperglycemic conditions in in 
vitro and in vivo models. 
Study Design: H9c2 cardiomyocyte cells were used as in vitro models and adult male Wistar strain 
albino rats were used as in vivo models. Activities of LDH and levels of lipid peroxides, total 
reduced glutathione were the end point indicators for the in vitro studies.  For the in vivo studies the 
activities of membrane bound ATPases, levels of lipid peroxides, enzymic and non enzymic 
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antioxidants were the end point indicators.   
Place and Duration of Study: The study was conducted at the Department of Microbiology and 
Biotechnology, Bangalore University, Bangalore, between January 2014 and June 2014. 
Methodology: To mimic myocardial injury during diabetic conditions (in vitro), the H9c2 cells were 
maintained in high glucose environment followed by isoproterenol challenge. For in vivo studies the 
animals were segregated as follows: Untreated control; Myocardial stress induced animals 
(Isoproterenol 150 mg/kg body wt i.p); Diabetic rats (Streptozotocin, 50 mg/kg body wt,i.p);  
Myocardial stress induced diabetic rats; resveratrol per se (5 mg/kg.body wt. orally for 21 days), 
and resveratrol pretreated prior to induction of diabetes and myocardial stress.  
Results: H9c2 cells given glucose insult and challenged with isoproterenol showed severe 
cytotoxicity and stress as elicited by increased LDH release, increased lipid peroxides and depleted 
GSH levels. These changes were prevented in the cells pretreated with resveratrol prior to 
isoproterenol/glucose challenge. The diabetic rats induced with myocardial stress showed 
significant alterations in the activity of membrane bound phosphatases, levels of lipid peroxides, 
enzymic and non enzymic antioxidants. Pre-treatment with resveratrol prevented these alterations 
thereby implicating cardioprotective effects during hyperglycemic conditions 
Conclusion: Resveratrol could combat myocardial stress during experimental hyperglycemia in in 
vitro and in vivo models.  
 
 
Keywords: Resveratrol; isoproterenol; myocardial stress; streptozotocin; type 1 diabetes. 
 
1. INTRODUCTION 
 
Free radicals play an important role in a number 
of biological processes, some of which are 
necessary for life, such as the intercellular killing 
of bacteria by phagocytic cells such as 
granulocytes and macrophages [1]. Free radical 
production occurs continuously in all cells as 
part of normal cellular function. However, excess 
free radical production originating from 
endogenous or exogenous sources might play a 
role in many diseases including diabetes and 
cardiovascular disease. There are a number of 
mechanisms to minimize the free radical 
induced damage and to repair the damage that 
occurs. The enzymic and non enzymic 
antioxidants play an important role in negating 
the damage induced by free radicals in 
biological systems [2]. Antioxidant 
supplementation has been proved to be 
beneficial to negate the oxidative damage 
induced in animals and humans. 
 
Diabetes mellitus is a globally recognized 
modern day epidemic which is characterized by 
chronic hyperglycemia due to abnormal insulin 
secretion or insulin receptor and post receptor 
events affecting metabolism of carbohydrate, 
protein and lipids [3]. Patients with Diabetes 
mellitus are at increased risk for the development 
of cardiovascular diseases and other 
macrovascular complications. Enhanced 
oxidative stress and depleted antioxidant status 
in diabetics makes them highly vulnerable to 
cardiac injury and predispose them for 
myocardial infarction one of the lethal 
manifestations of cardiovascular disease [4]. 
Myocardial infarction remains the major cause of 
death in the developed and developing world and 
hence is a major pathological issue worldwide 
despite rapid advancements made in the 
treatment of Coronary Artery Diseases (CAD). 
According to the World Health Organization 
(WHO) myocardial infarction is predicted to be 
the major cause of mortality in the world by the 
year 2020 [5]. 
 
Streptozotocin is a glucosamine-nitrosourea 
compound. This compound is particularly toxic to 
the insulin-producing beta cells of the pancreas 
in mammals. It is extensively used in research to 
produce animal models for type-1 diabetes [6]. 
Streptozotocin (STZ) can induce in susceptible 
hosts direct beta cell cytotoxicity and cell 
mediated auto immune reactions [7]. These 
factors acting separately or in concert appear to 
induce destructive insulitis and severe diabetes 
in animals within a short span of time. 
 
Isoproterenol (ISO) is a β1- and β2-
adrenoreceptor agonist that causes severe 
stress in the myocardium, resulting in infarct like 
necrosis of the heart muscle. Persistent beta 
adrenergic stimulation with isoproterenol leads to 
the development of oxidative stress, myocardial 
inflammation, thrombosis, platelet aggregation 
and calcium overload which ultimately culminates 
in myocardial infarction [8]. Isoproterenol being a 
dual β1- and β2 adrenergic receptor agonist has, 
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acute positive chronotropic and inotropic effects 
on the heart. When administered chronically or at 
high doses, isoproterenol has deleterious effects 
on the heart inducing hypertrophy, necrosis, 
fibrosis, apoptosis, oxidative damage and 
inflammatory cell infiltration [9]. On autooxidation 
isoproterenol generates highly cytotoxic free 
radicals known to stimulate peroxidation of 
membrane phospholipids and cause severe 
damage to the myocardial membrane [10]. 
Isoproterenol induced cardiac hypertrophy is a 
reliable, reproducible and well characterized 
model of cardiac hypertrophy associated with 
arrhythmias, myocyte loss, and fibrosis with the 
progression to heart failure [11]. 
 
In the recent years, antioxidants especially 
polyphenols have gained a lot of attention and 
have proved to be a promising strategy in the 
prevention of oxidative damage and cellular 
injury. Resveratrol(3,5,4’-trihydroxystilbene) a 
polyphenolic compound produced in the plants 
as a response to injury, ultraviolet irradiation, or 
fungal attack is a phytoalexin, phytoestrogen 
that is found mainly in the skin of grapes, 
mulberries and peanuts. Resveratrol is found to 
have diverse biological and pharmacological 
activities in vitro and as well as in vivo. It is 
reported to possess free radical scavenging [12], 
anticarcinogenic [13], anti-inflammatory [14], 
estrogenic activities [15] as well as 
cardiovascular protection [16] and 
neuroprotection [17]. Several lines of evidence 
from epidemiological studies revealed an 
inverse relationship between red wine 
consumption and the risk of cardiovascular 
diseases [18]. Numerous studies suggest that 
resveratrol inhibits lipid peroxidation of low 
density lipoprotein (LDL) prevents the 
cytotoxicity of oxidized LDL and protects cells 
against highly hydrophilic and lipophilic 
properties. It has been reported to provide more 
effective protection than other well-known 
antioxidants such as vitamin C and E [19]. The 
antioxidant effects of resveratrol are reported to 
contribute for its strong cardioprotective actions 
which have been experimentally proven in 
several experimental models of ischemia and 
myocardial infarction [20]. Reduced platelet 
aggregation and vasorelaxation has also been 
demonstrated in studies with resveratrol thereby 
indicating its thromobolytic actions and its 
possible role in cardio protection [21]. The 
vasorelaxant activity of resveratrol has been due 
to its ability to stimulate Ca2+ activated K+ 
channels and to enhance nitric oxide signaling in 
the endothelium. 
An important aspect of myocardial Na+ K+ pump 
in heart disease is its influence on extracellular 
potassium homeostasis. Two important aspects 
should be considered: potassium handling 
among myocytes, and effects of potassium 
entering the extracellular space of the heart via 
the bloodstream. It should be noted that both of 
these aspects of Ke homeostasis are affected by 
regulatory aspects, eg, regulation of the 
sodium/potassium pump by physiological and 
pathophysiological conditions, as well as by 
medical treatments. Peroxidation of membrane 
phospholipids not only alters the lipid mileu and 
structural as well as functional integrity of cell 
membranes, but also affects the various 
membrane bound enzyme activities including 
Ca2+ ATPase, Mg2+ ATPase and Na+ K+ ATPase 
[22,23]. As the membrane bound phosphatases 
play a major role in maintaining the integrity of 
cardiac membrane the present study was 
undertaken to understand the membrane 
protective and preconditioning effect of 
resveratrol against β –adrenergic stimulation 
during hyperglycemic conditions [24]. 
 
Although the cardio protective effects of 
resveratrol is well established, there are very few 
reports only on the effects of resveratrol in 
combating myocardial stress during diabetogenic 
conditions and currently there are no reports 
pertaining to the effects of resveratrol on the 
activities of membrane bound ATPases and 
antioxidant enzymes in diabetic animals induced 
with myocardial stress. Hence the objective of 
the current study is to evaluate the influence of 
resveratrol in protecting the myocardium against 
experimental injury induced by beta adrenergic 
stimulation with isoproterenol under 
hyperglycemic conditions. The results of the in 
vivo studies on rat models were compared with in 
vitro studies on rat cardiomyocyte models (H9c2 
cells) to have a better understanding of the 
protective effects of resveratrol on 
cardiomyocytes. 
 
2. MATERIALS AND METHODS 
 
2.1 Chemicals  
 
Isoproterenol (ISO), Streptozotocin (STZ/), 
Resveratrol (RSV) and Thiobarbituric acid (TBA) 
and Glutathione were purchased from Sigma 
Chemical Company, St.Louis, MO,USA. Sterile 
ready to use Dulbecco’s Modified Essential 
Medium (DMEM - AL007), Fetal Bovine Serum 
(FBS- RM1112), Trypsin-EDTA (T-001), 
Antibiotic antimycotic solution (A002) were 
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procured from Himedia Laboratories Pvt Limited, 
Mumbai, India. All the other chemicals used were 
of analytical grade and were purchased from the 
local chemical companies.  
  
2.2 Animals and Treatment 
 
Adult Wistar strain male albino rats weighing 
about 120 g – 140 g were procured from the 
approved sources of Bangalore University (M/s 
Raghavendra Enterprises, Bangalore). They 
were kept under quarantine for a period of two 
weeks. The animals were maintained under 
standard laboratory conditions with 12 hrs night 
and day cycle and were fed with commercial 
pelleted rat chow (M/S Hindustan Lever Limited, 
Bangalore, India) and water ad libitum. This part 
of the study which involved the usage of animals 
was approved by the Institutional Animal Ethics 
Committee (IAEC), Bangalore University 
(Approval no: Dr MSP-SU/RP/IAEC/BUB dated 
09/05/2011), Bangalore-560056.   
 
2.3 Procurement and Maintenance of H9 
c2 Cell Line 
 
The cardiomyocyte cell line H9c2 was procured 
from the National Center for Cell Science, Pune, 
India and cultured in sterile ready to use 
Dulbecco’s Modified Essential Medium (DMEM) 
supplemented with 10% Fetal Bovine Serum and 
antibiotic antimycotic solution. Cells were grown 
under standard growth conditions (Temperature 
37ºC, 95% humidity and 5% CO2) in a CO2 
incubator (Forma Scientific, USA). When a 
confluent monolayer was formed, the cells were 
detached with 0.25% Trypsin-0.2% EDTA in 
Dulbecco’s phosphate buffered saline and then 
subcultured at a split ratio of 1: 3 in a 12.5cm2 
tissue culture flask. The media was changed 
three times a week. The cells were grown in a 
growth medium containing 10% FBS or 
maintenance medium containing 5% FBS. On 
arriving at confluency, the cells were plated on to 
96 well microtiter plates (TPP-96, Himedia, India) 
and were utilized for different in vitro assays. 
 
2.4 In vitro Assays for Assessing the 
Influence of Resveratrol on 
Cardiomyocyte Viability and Integrity 
 
Induction of hyperglycemic conditions and stress 
on cardiomyocyte cells in vitro by challenge with 
glucose and isoproterenol- In vitro models to 
mimic myocardial stress in diabetic conditions. 
On arriving at confluency, the cells (5 X 106 
cells/ml) were plated on to 96 well microtiter 
plate. The cells were allowed to attach overnight 
and then pretreated with resveratrol (30µg/ml for 
30 minutes) [25,26]. Following this, experimental 
hyperglycemic conditions were induced in H9 c2 
cells by exposing them to high concentration of 
glucose (30 mM/L) [27] for 24 hours. After 24 
hours, the cells were treated with isoproterenol 
(100 µmoles/L) for 8 hrs [28]. A group of cells 
were challenged with glucose/isoproterenol at 
the same dose specified above and then treated 
with resveratrol (30 µg/ml for 30 minutes) to 
understand if resveratrol treatment could reverse 
the damage inflicted on the myocardium (post 
treatment schedule). 
 
2.4.1 Cytotoxicity assessment by LDH 
leakage 
 
After the different treatment periods, the effect of 
resveratrol pretreatment and post treatment on 
cell viability was determined by measuring the 
LDH leakage into the culture supernatant using a 
commercially available kit (Span Diagnostics, 
India) following the manufacturer’s instructions. 
 
2.4.2 Estimation of lipid peroxides 
 
Lipid peroxide levels in the treated and untreated 
cells in vitro were determined by the method 
previously described by [29]. Briefly 200 µl of cell 
culture supernatant after the treatment was 
mixed with 0.5ml glacial acetic acid and 2.0 ml of 
trichloro acetic acid was added and mixed well. 
The mixture was then centrifuged (3000 g) at 
room temperature for 10 minutes to separate the 
proteins. 2 ml of the supernatant was taken,               
0.5 ml of 1% TBA was added to it followed by 
heating at 95ºC for 60 minutes to generate the 
pink coloured malondialdehyde (MDA). The 
absorbance of the sample was read at 530 nm. 
Results were expressed as n moles of MDA/mg 
protein. 
 
Malondialdehyde content of the heart tissue was 
measured according to the procedure of Ohkawa 
et al. [30] using 1,1,3,3 tetramethoxy propane as 
standard.  Briefly, to 100 µl of homogenate  200 
µl of 8.1% SDS, 1.5 ml of 20% acetic acid, 1.5 ml 
of 0.8% aqueous TBA solution was added and 
the solution was made up to 4 ml.  The solution 
was heated on boiling water bath for 60 minutes, 
cooled and 1 ml of distilled water is added.  5 ml 
butanol and pyridine (15:1) is added and the 
mixture was shaken well. The mixture was then 
centrifuged at 4000 rpm for 10 minutes. The 
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absorbance of orange layer was read at 532 nm. 
Results were expressed as n moles of MDA/mg 
protein. 
 
2.4.3 Estimation of total reduced glutathione 
(GSH) 
 
The non-enzymatic antioxidant reduced 
glutathione was determined following the 
protocol described by Moron et al 1979 [31]. 
1.0ml of cell culture supernatant of treated and 
untreated cells (for in vitro studies) or heart 
tissue homogenate (for in vivo studies) were 
precipitated with 1.0 ml of TCA and the 
precipitate was removed by centrifugation. To 0.5 
ml of supernatant, 2.0 ml of DTNB was added 
and the total volume was adjusted to 3.0 ml with 
phosphate buffer. The absorbance was read at 
412 nm. Results were expressed as n moles of 
GSH/mg protein. 
 
2.5 Segregation of the Experimental 
Animals for in vivo Studies and 
Biochemical Assays 
 
After the quarantine period, the animals were 
divided into six groups according to the following 
experimental regimen. Group 1 comprised 
control animals. Group 2 comprised animals 
which were induced with myocardial stress by 
giving two intraperitoneal injections of 
isoproterenol (150 mg/kg body wt/ day in 
physiological saline) at an interval of 24 hrs. 
Group 3 animals were induced with diabetes by 
giving a single intraperitoneal injection of STZ 
(50 mg/kg body wt/day). Group 4 were animals 
which were induced with myocardial stress after 
the induction of diabetes. Precisely, these groups 
of animals were administered with STZ at the 
specified dose. 48 hours after the injection of 
STZ, fasting blood sugar was determined in the 
animals. Animals which had glucose levels of > 
200mg/dl were considered diabetic [32]. Such 
animals were selected for the induction of 
myocardial stress by the injection of 
isoproterenol. Group 5 were animals which were 
treated with resveratrol (5 mg/kg body wt. /day 
orally for 21 days. Group 6 were rats which were 
pretreated with resveratrol (5 mg/kg body wt. 
orally for 21 days) prior to the induction of 
diabetes and myocardial stress. (This dose was 
fixed based on preliminary studies conducted to 
understand the dose and time response of 
resveratrol in protecting the myocardium based 
on the activities of creatinine kinase in the serum 
of control and other groups of animals). 
Throughout the experimental period, the body 
weight of the animals were recorded and food 
intake monitored by visual observation at regular 
intervals. 
 
After the experimental period (36 hrs after the 
second injection of isoproterenol) the animals 
were sacrificed following the guidelines specified 
by the IAEC. The thoracic cavity of the animals 
were opened, the heart was dissected out, 
washed with ice-cold isotonic saline and then 
blotted to dryness. The weight of the heart was 
measured and recorded for the different groups 
of the animals. The cardiac tissue obtained from 
different groups of animals was homogenized in 
50 mM phosphate buffer (pH 7.0).  Supernatant 
was used for assaying the activities of membrane 
bound phosphatases viz., Calcium ATPase [33], 
Sodium Potassium ATPase [34] and Magnesium 
ATPase [35]. The activities of Glutathione 
peroxidase [36], levels of total reduced 
glutathione [31] and lipid peroxides [30] were 
also estimated in the heart of the treated animals 
and untreated control animals. 
 
2.6 Statistical Analysis 
 
For in vitro assays all the experiments were 
carried out in triplicate on at least three different 
occasions and the mean of the replicate values 
were taken. Values were expressed as mean ± 
SD (n= 6). Statistical analysis of the data was 
determined by Student’s t-test, P values were 
determined and comparisons were made 
between the untreated control cells and the 
treated cells.  
 
For in vivo experiments statistical analysis was 
carried out by Student’s t-test and values were 
expressed as mean ± SD (for six animals in         
each group). The P values were determined                
and intergroup comparisons were made. 
Comparisons were made between Group 2, 3, 4, 
5 Vs Group 1; Group 6 Vs Group 4. 
 
3. RESULTS 
 
3.1 Effect of Resveratrol Treatment on 
LDH Release during High Glucose 
Challenge Followed by Stimulation of 
H9c2 Cells with Isoproterenol 
 
Fig. 1 shows the effect of resveratrol pre and 
post treatment (30 µg/ml for 30 minutes prior to 
glucose/isoproterenol challenge or after 
challenge with glucose/isoproterenol as the case 
may be) on LDH release in H9c2 cells. Results 
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indicate that the cells treated with high 
concentration of glucose followed by stimulation 
with isoproterenol resulted in loss of membrane 
integrity, increased permeability of the 
membrane resulting in increased leakage of LDH 
which was found to be statistically significant (P 
<0.001). Pretreatment with resveratrol was able 
to preserve the integrity of the myocardial 
membrane as elicited by the decreased leakage 
of LDH into the culture supernatant as compared 
to the glucose/isoproterenol challenged group of 
cells and exhibiting nonsignificant changes when 
compared with untreated control. H9c2 cells 
treated only with resveratrol did not show any 
significant increase in the release of LDH as 
compared to the control thereby showing the 
absence of adverse toxic effects of resveratrol at 
the dose employed. The group of cells post 
treated with resveratrol after challenge with 
glucose and isoproterenol also showed a 
significant increase in the leakage of LDH. This 
implicate that resveratrol post treatment is 
ineffective to reverse the damage induced by 
glucose/isoproterenol and its effects on the 
myocardium is preventive rather than curative. 
 
3.2 Effect of Resveratrol Treatment on the 
Levels of Lipid Peroxides and Total 
Reduced Glutathione during High 
Glucose Challenge Followed by 
Stimulation of H9c2 Cells with 
Isoproterenol 
 
Table 1 shows the levels of lipid peroxides and 
total reduced glutathione during 
glucose/isoproterenol challenge in H9c2 cells. 
Results indicate that the group of cells treated 
with glucose/isoproterenol showed clear signs of 
oxidative stress and peroxidative damage as 
elicited by the increased levels of lipid peroxides 
and depleted glutathione levels as compared to 
untreated control cells (P< 0.001). Cells 
pretreated with resveratrol were protected 
against this oxidative damage which is supported 
by the enhanced glutathione status and reduced 
lipid peroxide levels as compared to 
glucose/isoproterenol challenged H9c2 cells. 
Post treatment of the cells with resveratrol 
following glucose/isoproterenol challenge failed 
to protect the cells against the oxidative damage 
which is evident from the statistically significant 
increase in the lipid peroxides and total reduced 
glutathione levels as compared to untreated 
control and nonsignificant changes with respect 
to lipid peroxide levels as compared to 
isoproterenol challenged cells exposed to high 
glucose. 
3.3 Effect of Resveratrol on the Activities 
of Membrane Bound Phosphatases in 
the Heart of Control and Experimental 
Animals 
 
Table 2 shows the effects of resveratrol (RSV) on 
the activities of membrane bound phosphatases 
(Na+ /K+ ATPase, Ca2+ ATPase and Mg2+ATPase) 
in the heart tissue of different groups of rats. 
Results implicate that the activity of Na+ /K+ 
ATPase showed a decrease, whereas the Ca2+ 
ATPase and Mg2+ ATPase showed an increase 
in the Group 2 (ISO only) and Group 4 (ISO + 
STZ) rats as compared to the untreated control 
rats. The change in enzyme activity observed in 
Group 2 and Group 4 rats was found to be 
statistically significant (P< 0.001).The Group 5 
rats given resveratrol per se did not show any 
significant change in the activities of all the three 
membrane bound phosphatases studied as 
compared to the Group 1 control animals thereby 
implicating the nontoxic effects of resveratrol on 
the myocardium at the dose employed. The 
Group 6 diabetic rats pretreated with resveratrol 
for 21 days prior to the induction of myocardial 
stress showed an increase in the activity of 
sodium potassium ATPase concomitant with a 
decrease in the activities of Calcium ATPase and 
Magnesium ATPase as compared to that of 
Group 4 (ISO + STZ) animals thereby implicating 
the ability of resveratrol to prevent the 
detrimental changes in the myocardial 
membrane during isoproterenol challenge under 
experimentally induced hyperglycemic 
conditions. 
 
3.4 Effect of Resveratrol on the Levels of 
Lipid Peroxides (LPO), Total Reduced 
Glutathione (GSH) and Activity of 
Glutathione Peroxidase (GPx) in the 
Heart of Normal and Experimental 
Groups of Rats 
 
Table 3 shows the levels of lipid peroxides, total 
reduced glutathione and the activity of 
glutathione peroxidase in the heart of control and 
experimental groups of rats. The levels of lipid 
peroxides showed a statistically significant (P< 
0.001) increase in the Group 2, 3 and 4 rats as 
compared to the untreated control. The Group 5 
rats given resveratrol per se showed non-
significant changes in the levels as compared to 
the Group 1 control animals. The Group 6 rats 
pretreated with resveratrol for 21 days prior to 
the induction of myocardial stress showed a 
significant decrease in the levels of lipid 
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peroxides in the heart as compared to the Group 
4 rats thereby indicating the antiperoxidative 
effects of resveratrol and its inhibitory effect                     
of lipid peroxidation chain reaction.
 
 
 
Fig. 1. Effect of resveratrol on LDH leakage during high glucose/isoproterenol challenge in H9 
c2 cells 
Values were expressed as mean ± SD (n=6). Statistical analysis by Students’- t- test. Comparisons were made 
between Group 1 Vs Group 2; Group 3 and Group 2 Vs Group 4; Group 5.***P< 0.001; NS- Non significant. Activity 
of LDH expressed as IU/L 
 
Table 1. Effect of resveratrol on the levels of lipid peroxides and total reduced glutathione 
during high glucose/isoproterenol challenge in H9c2 cells 
 
Groups Lipid peroxides (LPO) Total reduced glutathione (GSH) 
1 0.29±0.05 0.61±0.05 
2  0.71±0.08*** 0.27±0.04*** 
3 0.24±0.03* 0.68±0.06NS 
4 0.49±0.04*** 0.54±0.03*** 
5 0.69±0.08 NS  0.31±0.02** 
Values were expressed as mean ± SD (n=6). Statistical analysis by Students’- t- test. Comparisons were made 
between Group 1 Vs Group 2;Group 3 andGroup 2 Vs Group 4, Group 5. ***P< 0.001; *P< 0.05; 
**P < 0.01; NS- Non significant. Levels of LPO expressed as n moles of MDA/mg protein and n moles of GSH/mg 
protein 
 
Table 2. Effect of resveratrol treatment on the activities of membrane bound phosphatases in 
the untreated control and treated groups of rats 
 
Groups Na/K+ ATPase   Ca2+ATPase Mg2+ ATPase 
1 5.36±0.61   1.46±0.2 6.89±0.75 
2 2.20±0.35***   6.31±0.50*** 10.58±1.23*** 
3 3.10±0.37***   4.01±0.46*** 9.54±0.82*** 
4 1.91±0.20***   6.98±0.53*** 10.72±1.96*** 
5 4.11±1.50 NS   1.76±0.28 NS 6.97±0.78 NS 
6 3.67±0.25***   2.20±0.36*** 8.52±0.93* 
Values were expressed as mean ± SD (n=6). Statistical analysis by Students’- t- test. Inter group comparisons 
were made. Comparisons were made between Group 2, Group 3, Group 4, Group 5 Vs Group 1; Group 6 vs 
Group 4.***P< 0.001; *P< 0.05;  NS- Non significant. Activity expressed as units: µ mol of phosphorus 
liberated/min/mg protein 
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Table 3. Effect of resveratrol pretreatment on the levels of lipid peroxides, total reduced 
glutathione (GSH) and activity of Glutathione peroxidase during isoproterenol induced 
myocardial stress in diabetic rats 
 
Groups Lipid peroxides 
(nmoles/mg of protein)  
Gpx 
(µg of GSH 
consumed/min/mg protein) 
GSH 
(n moles/mg  protein) 
1 0.42±0.06  41.3±1.0 35.7±0.5 
2 0.68±0.08*** 31.7±0.7*** 24.5±0.9*** 
3 0.84±0.04*** 29.7±0.9*** 29.5±2.0 *** 
4 1.37±0.02*** 16.8±0.4*** 18.2±2.0*** 
5 0.48±0.10 NS 43.9±0.8 NS 36.2±2.2NS 
6 0.38±0.06 *** 34.9±0.9*** 32.3±4.9*** 
Values were expressed as mean ± SD (n = 6). Statistical analysis by Students’- t- test. Inter group comparisons 
were made. Comparisons were made between Group 2, Group 3, Group 4, Group 5 Vs Group1; Group 6 Vs 
Group 4. ***P< 0.001; NS- Non significant 
 
Interestingly, it was found that the levels of lipid 
peroxides of Group 6 rats were much reduced 
than the control showing a strong 
antiperoxidative effect. 
 
The results also indicate that the Group 2, 3 and 
4 rats showed a significant depletion in GSH (P< 
0.001) levels concomitant with a significant 
decrease in the activity of glutathione peroxidase 
(P< 0.001) as  compared to the untreated control 
rats. This indicate the defective antioxidant status 
in diabetic rats and diabetic rats induced with 
myocardial stress. The Group 5 rats given 
resveratrol per se did not show any significant 
change in the activity of glutathione peroxidase 
and total reduced glutathione as compared to the 
Group 1 control animals. This indicate the 
absence of any adverse changes on treatment 
with resveratrol. The Group 6 rats pretreated with 
resveratrol for 21 days prior to the induction of 
myocardial stress showed a significant increase 
in the activity of glutathione peroxidase coupled 
with an enhancement in the levels of GSH in the 
heart thereby confirming the strong antioxidant 
effects of resveratrol as a result of which there is 
a replenishment in the levels of glutathione and 
normalization of glutathione antioxidant defense 
hence preventing the oxidative tissue damage in 
animals. 
 
4. DISCUSSION 
 
Nutrition can play an important role in the 
modulation of pathological conditions and thus 
can delay the onset and progression of many 
dreadful diseases in humans. Nutritional support 
and dietary intervention has always proven to be 
an important therapeutic strategy in the 
management of many life style diseases 
including diabetes and cardiovascular diseases. 
Antioxidants have gained considerable research 
importance in the recent years owing to their 
health benefits and multifaceted protective 
effects. Resveratrol is a phytoalexin, 
polyphenolic antioxidant and phytoestrogen 
reported to possess cardio protective properties 
owing to its strong antioxidant effect. It is a major 
component in red wine and is believed to be 
responsible for the low incidence of 
cardiovascular diseases in the French, in spite of 
consumption of a high fat diet. Several studies in 
the last two decades have demonstrated that 
resveratrol may prevent or slow the progression 
of a wide variety of human diseases including 
cancer, cardiovascular diseases, and ischemic 
injuries as well as to enhance stress resistance 
and extend the life span of a variety of organisms 
from yeast to vertebrates [37]. In the current 
study the ability of resveratrol treatment to 
protect the myocardium against beta adrenergic 
stimulation during experimentally induced 
diabetic conditions was investigated in in vivo 
and in vitro models. This will enable to 
understand if resveratrol supplementation could 
be beneficial in diabetic population predisposed 
to develop cardiovascular disease in the later 
part of life.  
 
The myoblast cell line H9c2, derived from 
embryonic rat heart [38] has been used as an in 
vitro model for both skeletal and cardiac muscle. 
H9c2 cells show electrophysiological and 
biochemical properties of both skeletal and 
cardiac tissues, including depolarization in 
response to acetylcholine, and rapid activation of 
calcium currents through L-Type channels. An 
interesting feature of this cell line is its ability to 
differentiate from mono nucleated myoblasts to 
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myotubes upon reduction of serum concentration 
[39]. During the differentiation process, these 
cells retain several elements of the electrical and 
hormonal signaling pathway of cardiac cells [38].  
and have therefore become an accepted in vitro 
model to study the effects of ischemia and 
diabetes on the heart [40]. 
 
In the current study, the efficacy of resveratrol 
pretreatment to maintain membrane integrity was 
determined by measuring the activity of lactate 
dehydrogenase (LDH) in the culture supernatant 
following high glucose/isoproterenol challenge. 
LDH is normally present in the cytosol, and 
cannot be measured extracellularly unless cell 
membrane damage has occurred. It has been 
shown that changes in metabolic activity are 
better indicators of early cell injury and that 
effects on membrane integrity are indicative of 
more serious injury leading to cell death. 
Increased leakage of LDH into the culture 
supernatant following treatment of H9c2 cells 
with high glucose/isoproterenol implicate the 
severity of myocardial membrane damage 
inflicted experimentally thereby resulting in a 
leaky myocardial membrane. Reduced levels of 
LDH in cells pretreated with resveratrol prior to 
induction of stress on the cells, indicate the 
strong cytoprotective /cardio protective effects of 
resveratrol. This could be attributed to the 
previously reported pharmacological 
preconditioning effect of resveratrol eliciting 
appreciable protective effects [41]. Failure to 
prevent the leakage of LDH in cells post                
treated with resveratrol following high 
glucose/isoproterenol challenge indicate that the 
protective effects offered by resveratrol is 
preventive rather than curative. 
 
Myocardial injury during diabetes is accompanied 
by increased oxidative stress, depleted 
antioxidant status and per oxidative membrane 
damage. Hence to understand the ability of 
resveratrol to prevent myocardial stress and lipid 
peroxidation, the levels of total reduced 
glutathione and lipid peroxides were estimated in 
the current study.  Enhanced lipid peroxidation 
and depletion in the levels of total reduced 
glutathione are suggestive of severe oxidative 
stress and defective antioxidant status in the 
H9c2 cells given high glucose/isoproterenol 
insult. Resveratrol pretreatment very effectively 
prevented the depletion of thiol status and 
inhibited the lipid peroxidation reaction which 
could be attributed to the strong antioxidant 
effects of resveratrol. As observed with LDH 
leakage, post treatment of the cells with 
resveratrol was ineffective in repairing the 
damage inflicted by challenge with high 
glucose/isoproterenol thereby reiterating that 
resveratrol treatment is very effective in 
preventing the damage rather than repairing the 
damage induced in the myocardium. 
 
This was further supported by the results of in 
vivo studies on rats in which pretreatment with 
resveratrol was able to efficiently prevent lipid 
peroxidation and improve glutathione antioxidant 
defense status thereby protecting the 
myocardium against oxidative stress induced by 
isoproterenol in diabetic rats. Hence the results 
of in vivo studies were in agreement with the in 
vitro studies and complement each other. 
 
Free radical production occurs continuously in all 
cells as part of normal cellular function. However, 
excess free radical production originating from 
endogenous or exogenous sources might play a 
role in many diseases. The degree of tissue 
damage persuaded by free radicals depends on 
the balance between free radical generation and 
the endogenous antioxidant defense mechanism 
[42]. Antioxidants prevent free radical induced 
tissue damage by preventing the formation of 
radicals, scavenging them or by promoting their 
decomposition [43]. This could be the reason for 
the decreased lipid peroxide levels and 
increased glutathione status in the cells treated 
with resveratrol prior to the induction of stress. It 
has been reported that resveratrol is an efficient 
scavenger of OH- and O2– radicals [44] that could 
account for its cardio protective effects. GSH is a 
major intracellular non protein sulfhydryl 
compound and is accepted as the most important 
intracellular hydrophilic antioxidant [45]. GSH 
acts as a cosubstrate for glutathione peroxidase 
and as a cofactor for many enzymes. Stress 
resistance of many cells is associated with high 
intracellular levels of GSH. A decreased GSH 
content may predispose the cells to lower 
defense against condition of oxidative stress 
during several degenerative disease conditions 
including aging and diabete [46,47]. The 
replenishment in glutathione status coupled with 
an enhancement in glutathione peroxidase 
activity in the resveratrol pretreated animals 
implicate the ability of resveratrol to negate the 
oxidative damage and maintain the antioxidant 
status thereby exerting its protective effects on 
the heart. 
 
Further, to understand the effects of resveratrol 
in modulating the functions of ionic pumps and 
thereby regulate the movement of sodium, 
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potassium, calcium and magnesium into and out 
of the cell, the activities of membrane bound 
phosphatases were investigated in the control 
and experimental groups of animals. ATPases 
are lipid dependent, membrane-bound enzymes 
involved in active transport process and have 
been implicated in the pathogenesis [48] of 
several diseases. Alterations in the activities of 
membrane bound enzymes are reported to affect 
the function of the heart. Vajreshwari et al. [49] 
reported that the failure of the cell membrane to 
maintain normal transmembrane ionic distribution 
through ion pumps is considered to be a major 
event in the pathogenesis of ischemia and 
arrhythmia. The role that  Na+/K+-ATPase plays 
in Na+ and K+ antiport through the sarcolemma, 
in cation-homeostasis in cardiomyocytes as well 
as in excitation contraction coupling and cell 
signaling in the myocardium is now widely 
recognized. The current study attempts to 
understand the role of resveratrol in modulating 
the activities of membrane bound ATPases 
thereby exhibiting cardio protection during 
experimental myocardial stress in diabetic 
animals. Decreased activity of Na+/K+-ATPase 
observed in the study in the Group 2 (ISO only), 
Group 3 (STZ only) and Group 4 (ISO + STZ) 
rats could be due to enhanced lipid peroxidation 
induced by Isoproterenol or Isoproterenol/STZ 
[50]. This in turn can lead to a decrease in 
sodium efflux, thereby altering membrane 
permeability [51]. Ca2+ ATPase is another 
membrane bound phosphatase that regulates the 
actions of the calcium pump [52]. Enhanced 
Ca2+-ATPase activity observed in Group 2 (ISO 
only) and Group 4 (ISO + STZ) rats could be due 
to the activation of adenylate cyclase by the 
isoproterenol. Mg2+ ATPase activity is involved in 
many energy requiring processes in the cell and 
its activity is sensitive to lipid peroxidation [48]. In 
the current study, pretreatment with resveratrol 
normalized the activities of these membrane 
bound enzymes in Group 6 (RSV+ISO+STZ) rats 
as compared to Group 4 (ISO + STZ) rats. 
Restoration of Na+/K+ ATPase activity due to 
resveratrol pretreatment in the Group 6 
(RSV+ISO+STZ) rats induced with myocardial 
stress could help to regulate the intracellular 
Ca2+ levels, thereby maintaining the membrane 
integrity and protecting the myocardium from 
damage rendering it non leaky.  
 
5. CONCLUSION 
 
Overall, the present study suggests that 
pretreatment with the polyphenol resveratrol 
preserves the cardiomyocytes against damage 
inflicted by experimental injury and oxidative 
stress. Resveratrol pretreatment in animals 
modulate the activities of membrane bound 
phosphatases, enhances the antioxidative status 
and inhibits lipid peroxidation chain reaction and 
thereby protect myocardial membrane integrity. 
The protective effects of resveratrol observed on 
the myocardium are strongly believed to be 
preventive rather than curative. Avenues are 
wide open for resveratrol to be explored as a 
potent cardio protective agent during diabetic 
conditions. 
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